Currently, RGEN provides standalone products and solutions for the complete bioprocessing sequence and focuses on three key ...

Q3 2024 Earnings Call Transcript November 7, 2024 Pacific Biosciences of California, Inc. beats earnings expectations.

Besides highlighting its sequencers, the company also launched a program to help researchers who want to incorporate spatial transcriptomic into their research.

FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This is the ...

Rigorous surveillance of children at high risk for developing myelodysplastic syndrome (MDS) is especially warranted, ...

According to a new market research report, 'Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis ...

Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.

donor-derived cell-free DNA (dd-cfDNA), and uses a digital-PCR workflow that we believe offers distinct advantages over assays run on Next-Generation Sequencing (NGS) technology. Our scientists have ...

Planegg/Martinsried, November 11, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused ...

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and ...